H. pylori (Helicobacter pylori)

Ask a question or start a discussion
NEW TREATMENT ADDED BY A MEMBER
Mastic Gum supplements
Does not have scientific evidence that it can eradiate H Pylori but some people have reported positive results.
48% of users reported improvements
OTC
TRIED
TRYING
How effective is it?
REMOVE ANSWER
completely cured
significant improvement
minor improvement
no difference
worse than before
Helps with prevention
1 (5%)
3 (14%)
6 (29%)
10 (48%)
1 (5%)
ESSENTIAL RESEARCH
Helicobacter pylori infection and the development of gastric cancer.
Gastric cancer develops in persons infected with H. pylori but not in uninfected persons. Those with histologic findings of severe gastric atrophy, corpus-predominant gastritis, or intestinal metaplasia are at increased risk. Persons with H. pylori infection and nonulcer dyspepsia, gastric ulcers, or gastric hyperplastic polyps are also at risk, but those with duodenal ulcers are not.
...see more
READ MORE
0REPLY
NEW SYMPTOM ADDED BY A MEMBER
Yes
45
No
17
Stomach ache (Abdominal Pain)
73% reported this symptom
Pain in the stomach.
Exanqueca acompanhada de dor no peito e irradiada pra as costas
Dor de cabeça forte e dor no peito irradiando pra costas... ( Sensação de sufoco nos pulmões)
0REPLY11 MONTHS AGO
PROGRESS UPDATE
TREATMENT
Trying treatment Amoxicillin + Clarithromycin + PPI
SYMPTOM
Excessive gas marked as moderate
Fatigue marked as mild
Bloating marked as moderate
Show 34 more
0REPLY1 MONTH AGO
CLINICAL TRIALNot yet recruiting
Helicobacter Pylori Eradication and Irritable Bowel Syndrome: A Prospective Study
All genders
Phase 4
H. Pylori is frequently observed in patients with irritable bowel syndrome(IBS). However, the effect of H. pylori eradication on IBS is not clear.
LEARN MORE
0REPLY8 MONTHS AGO
Get important H. pylori (Helicobacter pylori) updates delivered to your email.
ESSENTIAL RESEARCH
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.
The global burden of gastric cancer is considerable but varies geographically. Eradication of H pylori infection has the potential to reduce the risk of gastric cancer development.
READ MORE
0REPLY
ESSENTIAL RESEARCH
A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain.
The Sydney strain of H. pylori is available to all and will provide a standardized mouse model for vaccine development, compound screening, and studies in pathogenesis.
READ MORE
0REPLY
NEW TREATMENT ADDED BY A MEMBER
Amoxicillin + Clarithromycin + PPI
A prescription combination of Amoxicillin, Clarithromycin, and a proton pump inhibitor taken at the same time.
78% of users reported improvements
2 reviews
Prescription
TRIED
TRYING
How effective is it?
REMOVE ANSWER
completely cured
significant improvement
minor improvement
no difference
worse than before
Helps with prevention
10 (56%)
2 (11%)
2 (11%)
3 (17%)
1 (6%)
NEW SYMPTOM ADDED BY A MEMBER
Yes
50
No
11
Burping (Belching)
82% reported this symptom
The release of gas from the digestive tract (mainly esophagus and stomach) through the mouth.
ESSENTIAL RESEARCH
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
We found that the incidence of gastric cancer development at the population level was similar between participants receiving H pylori eradication treatment and those receiving placebo during a period of 7.5 years in a high-risk region of China. In the subgroup of H pylori carriers without precancerous lesions, eradication of H pylori significantly decreased the development of gastric cancer. Further studies to investigate the role of H pylori eradication in participants with precancerous lesions are warranted.
...see more
READ MORE
0REPLY
CLINICAL TRIALNot yet recruiting
EFFICACY OF ORAL AROEIRA (Schinus Terebinthifolius Raddi), AMOXYCILLIN AND CLARITROMYCIN FOR Helicobacter Pylori ERADICATION IN GASTRITE AND SYMPTOM PATIENTS
All genders
Phase 2/Phase 3
This is a prospective, randomized, double - blind study of 200 male and female volunteers with gastritis diagnosed at the Oswaldo Cruz University Hospital Gastroenterology Outpatient Clinic from October 2019 to July 2020. . Hypothesis: As a non-inferiority study, the hypothesis is that the use of oral Aroeira (Schinus terebinthifolius raddi), associated with amoxicillin and clarithromycin, for the treatment of patients diagnosed with gastritis and dyspeptic symptoms has similar efficacy and safety (non-inferior) and/or superior efficacy and safety to traditional therapy based on the use of omeprazole-associated antibiotic therapy.
...see more
LEARN MORE
0REPLY8 MONTHS AGO
NEW TREATMENT ADDED BY A MEMBER
Amoxicillin + Rifabutin + Ciprofloxacin + PPI
A quadruple therapy for those who failed a triple therapy.
82% of users reported improvements
Prescription
TRIED
TRYING
How effective is it?
REMOVE ANSWER
completely cured
significant improvement
minor improvement
no difference
worse than before
Helps with prevention
12 (71%)
1 (6%)
1 (6%)
3 (18%)
0 (0%)
PROGRESS UPDATE
SYMPTOM
Excessive gas marked as moderate
Bloating marked as moderate
Fatigue marked as moderate
Show 21 more
0REPLY2 MONTHS AGO
ESSENTIAL RESEARCH
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial.
Prophylactic eradication of H pylori after endoscopic resection of early gastric cancer should be used to prevent the development of metachronous gastric carcinoma.
READ MORE
0REPLY
ESSENTIAL RESEARCH
Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts.
These results suggest that 5.9 is the best estimate of the relative risk of non-cardia cancer associated with H pylori infection and that H pylori does not increase the risk of cardia cancer. They also support the idea that when H pylori status is assessed close to cancer diagnosis, the magnitude of the non-cardia association may be underestimated.
...see more
READ MORE
0REPLY
ESSENTIAL RESEARCH
Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
When compared with uninfected subjects, persons infected with CagA positive H pylori are at considerably increased risk of gastric cancer. CagA negative H pylori are less strongly linked to malignancy and may only be associated with diffuse type disease.
READ MORE
0REPLY
CLINICAL TRIALEnrolling by invitation
Magnifying NBI Endoscopy for Gastric Condition
Seoul, Korea, Republic of
All genders
Recently, the improved resolution with standard endoscopy allows the close observation of highly inflamed gastric mucosa without a magnifying view. In a previous study, the investigators established the endoscopic classification of H. pylori-infected stomach by non-magnifying standard endoscopy. One normal RAC pattern and three types of abnormal patterns were observed. Overall diagnostic accuracy for predicting H. pylori-infection was 91.6%. However, there is no comparison study predicting H. pylori-infection and precancerous gastric lesions between standard and magnifying endoscopy.
...see more
LEARN MORE
0REPLY8 MONTHS AGO
ESSENTIAL RESEARCH
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms.
A proinflammatory cytokine genetic profile increases the risk of noncardia gastric adenocarcinoma but not other upper gastrointestinal cancers, possibly by inducing a hypochlorhydric and atrophic response to gastric H. pylori infection.
READ MORE
0REPLY
ABOUT
A bacteria found in the stomach and is known to cause ulcers and sometimes stomach cancer and other digestive issues.
SHOW MORE
Get the latest H. pylori (Helicobacter pylori) research, treatments, and clinical trials in your email.